419 Followers on Owler

Sarepta

is a Massachusetts-based biotechnology company that discovers and develops genetic medicines for the treatment of neuromuscular diseases... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Sarepta

is a Massachusetts-based biotechnology company that discovers and develops genetic medicines for the treatment of neuromuscular diseases... Read more
Sarepta President & CEO: Douglas S. Ingram

President & CEO

Douglas S. Ingram

CEO Approval Rating

69/100

1980

PublicNASDAQSRPT

Pharmaceuticals & Biotechnology
Biotechnology
2834 NAICS listing

Annual Revenue
$2.2B
Employees
840
Funding
$2.5B
Acquisitions
3
Investments
4

News

Partnership
Aug 27, 2025
Seeking Alpha
Elanco Animal Health set to join S&P MidCap 400, Sarepta to join S&P SmallCap 600

Sarepta Competitors

1Wave Life Sciences
2Dyne Therapeutics
3Avidity Biosciences
4PepGen
5Entrada Therapeutics
6Regenxbio
7Eidos
8Neurana
9Genentech
Unlock 6 + competitors

Trending Companies